Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

• Esperanza M Algarín,
• Andrea Díaz-Tejedor,
• Pedro Mogollón,
• Susana Hernández-García,
• Luis A. Corchete,
• Laura San-Segundo,
• Montserrat Martín-Sánchez,
• Lorena González-Méndez,
• Marie Schoumacher,
• Sebastien Banquet,
• Laurence Kraus-Berthier,
• Ioana Kloos,
• Alix Derreal,
• Ensar Halilovic,
• Heiko Maacke,
• Norma C. Gutiérrez,
• María-Victoria Mateos,
• Teresa Paíno,
• Mercedes Garayoa,
• Enrique M. Ocio

Affiliations

Esperanza M Algarín

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Andrea Díaz-Tejedor

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Pedro Mogollón

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Susana Hernández-García

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Luis A. Corchete

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Laura San-Segundo

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Montserrat Martín-Sánchez

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Lorena González-Méndez

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Marie Schoumacher

Institut de Recherches Servier, Suresnes, France

Sebastien Banquet

Institut de Recherches Servier, Suresnes, France

Laurence Kraus-Berthier

Institut de Recherches Servier, Suresnes, France

Ioana Kloos

Institut de Recherches Servier, Suresnes, France

Alix Derreal

Institut de Recherches Servier, Suresnes, France

Ensar Halilovic

Novartis Institutes for Biomedical Research, Cambridge, MA, USA

Heiko Maacke

Novartis Institutes for Biomedical Research, Basel, Switzerland

Norma C. Gutiérrez

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

María-Victoria Mateos

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Teresa Paíno

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Mercedes Garayoa

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain

Enrique M. Ocio

University Hospital of Salamanca (IBSAL)-Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain;University Hospital Marqués de Valdecilla (IDIVAL); University of Cantabria, Santander, Spain